7 results
8-K
EX-99.1
IVVD
Invivyd Inc
20 Sep 21
Adagio Therapeutics Provides COVID-19 Antibody Program Updates as well as Business
4:05pm
for the EVADE trial, and their support of our plans to expand enrollment to include adolescents and pregnant or nursing women,” said Lynn Connolly, M.D … 12 years and older and pregnant or nursing women, as well as a decrease in the protocol-specified, in-clinic post injection monitoring time
8-K
EX-99.1
IVVD
Invivyd Inc
10 Sep 21
Adagio Therapeutics Announces Expansion of Patient Population in Global Phase 2/3 Clinical Trial of ADG20 for the Prevention of COVID-19
7:55am
-19
Independent Data Monitoring Committee Supports Expansion to Adolescents and Pregnant and Nursing Women Based on Safety and Tolerability Data from … trial enrollment to include adolescents and pregnant or nursing women, as well as to decrease the protocol-specified, post injection monitoring time
424B4
IVVD
Invivyd Inc
6 Aug 21
Prospectus supplement with pricing info
4:54pm
to adolescents and pregnant women in the Phase 3 portion. In addition, an independent data monitoring committee, or iDMC, meeting is anticipated … from the first 200 adult participants across both cohorts in the Phase 2 portion of the trial, we may expand enrollment to adolescents and pregnant women
S-1/A
IVVD
Invivyd Inc
2 Aug 21
IPO registration (amended)
6:20am
women in the Phase 3 portion. In addition, an independent data monitoring committee, or iDMC, meeting is anticipated in the fourth quarter of 2021 … participants across both cohorts in the Phase 2 portion of the trial, we may expand enrollment to adolescents and pregnant women in the Phase 3 portion
S-1
IVVD
Invivyd Inc
16 Jul 21
IPO registration
4:56pm
States. After evaluation of safety data from the Phase 2 portion of the trial, we may expand enrollment to adolescents and pregnant women … across both cohorts in the Phase 2 portion of the trial, we may expand enrollment to adolescents and pregnant women in the Phase 3 portion.
We initiated
DRS/A
3hlj6 84a1sq4
28 Jun 21
Draft registration statement (amended)
12:00am
DRS
6to96
21 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next